0

Journal Articles

in Genetic Disorders
 121-140 of 188 Articles
Academic Innovations |  January 05, 2005
Scientists Scope Out Huntington Disease
JAMA. 2005;293(1):29. doi:10.1001/jama.293.1.29.
Medical News and Perspectives |  November 24, 2004
Growing Role for Umbilical Cord Blood
JAMA. 2004;292(20):2453-2456. doi:10.1001/jama.292.20.2453.
Health Law and Ethics |  September 22, 2004
The "Duty to Warn" a Patient's Family Members About Hereditary Disease Risks
Kenneth Offit, MD, MPH; Elizabeth Groeger, BA; Sam Turner, JD; et al.
JAMA. 2004;292(12):1469-1473. doi:10.1001/jama.292.12.1469.
Editorial |  September 15, 2004
Breast MRI for Women With Hereditary Cancer Risk
Mark E. Robson, MD; Kenneth Offit, MD, MPH
JAMA. 2004;292(11):1368-1370. doi:10.1001/jama.292.11.1368.
Medical News and Perspectives |  August 25, 2004
Scientists Use Neuroimaging, Genetic Studies to Probe Biology of Tourette Syndrome
JAMA. 2004;292(8):909-911. doi:10.1001/jama.292.8.909.
Health Agencies Update |  June 23, 2004
Stimulating Muscle Growth
JAMA. 2004;291(24):2933. doi:10.1001/jama.291.24.2933-e.
Editorial |  April 14, 2004
The WHI Estrogen-Alone Trial—Do Things Look Any Better?
Stephen B. Hulley, MD, MPH; Deborah Grady, MD, MPH
JAMA. 2004;291(14):1769-1771. doi:10.1001/jama.291.14.1769.
Editorial |  March 03, 2004
Cell-Free Fetal DNA in Maternal Blood:  Evolving Clinical Applications
Joe Leigh Simpson, MD; Farideh Bischoff, PhD
JAMA. 2004;291(9):1135-1137. doi:10.1001/jama.291.9.1135.
Medical News and Perspectives |  February 25, 2004
Merits of Embryo Screening Debated
JAMA. 2004;291(8):927-929. doi:10.1001/jama.291.8.927.
Original Contribution |  February 11, 2004 FREE
A Founder Mutation of the MSH2 Gene and Hereditary Nonpolyposis Colorectal Cancer in the United States
Henry T. Lynch, MD; Stephanie M. Coronel, MPH; Ross Okimoto, BS; et al.
JAMA. 2004;291(6):718-724. doi:10.1001/jama.291.6.718.
Original Contribution |  January 28, 2004 FREE
Penetrance of the Fragile X–Associated Tremor/Ataxia Syndrome in a Premutation Carrier Population
Sébastien Jacquemont, MD; Randi J. Hagerman, MD; Maureen A. Leehey, MD; et al.
JAMA. 2004;291(4):460-469. doi:10.1001/jama.291.4.460.
Original Contribution |  January 07, 2004 FREE
National Use of Postmenopausal Hormone Therapy:  Annual Trends and Response to Recent Evidence
Adam L. Hersh, MD, PhD; Marcia L. Stefanick, PhD; Randall S. Stafford, MD, PhD
JAMA. 2004;291(1):47-53. doi:10.1001/jama.291.1.47.
Original Contribution |  October 01, 2003 FREE
Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa:  A Randomized Controlled Trial
Lisa Saiman, MD, MPH; Bruce C. Marshall, MD; Nicole Mayer-Hamblett, PhD; et al.
JAMA. 2003;290(13):1749-1756. doi:10.1001/jama.290.13.1749.
Original Contribution |  August 27, 2003 FREE
Provision of Pneumococcal Prophylaxis for Publicly Insured Children With Sickle Cell Disease
Colin M. Sox, MD; William O. Cooper, MD, MPH; Thomas D. Koepsell, MD, MPH; et al.
JAMA. 2003;290(8):1057-1061. doi:10.1001/jama.290.8.1057.
The World in Medicine |  August 13, 2003
Beefing up Muscle
JAMA. 2003;290(6):740. doi:10.1001/jama.290.6.740-a.
Medical News and Perspectives |  May 21, 2003
Cause of Progeria's Premature Aging Found
JAMA. 2003;289(19):2481-2482. doi:10.1001/jama.289.19.2481.
Editorial |  April 02, 2003
Hydroxyurea and Sickle Cell Disease:  A Chance for Every Patient
Debra L. Weiner, MD, PhD; Carlo Brugnara, MD
JAMA. 2003;289(13):1692-1694. doi:10.1001/jama.289.13.1692.
Original Contribution |  April 02, 2003 FREE
Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia:  Risks and Benefits Up to 9 Years of Treatment
Martin H. Steinberg, MD; Franca Barton, MS; Oswaldo Castro, MD; et al.
JAMA. 2003;289(13):1645-1651. doi:10.1001/jama.289.13.1645.
From the Centers for Disease Control and Prevention |  March 26, 2003 FREE
Potential Exposures to Airborne and Settled Surface Dust in Residential Areas of Lower Manhattan Following the Collapse of the World Trade Center—New York City, November 4–December 11, 2001
JAMA. 2003;289(12):1498-1500. doi:10.1001/jama.289.12.1498.
Medical News and Perspectives |  March 19, 2003
Hemochromatosis Patients Are Untapped Source of Blood as War, Shortages Loom
JAMA. 2003;289(11):1364-1366. doi:10.1001/jama.289.11.1364.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Phenotypic Conservation in Patients With X-Linked Retinitis Pigmentosa Caused by RPGR Mutations
Sarwar Zahid, MD, MS; Naheed Khan, PhD; Kari Branham, MS; et al.
JAMA Neurology
Clinical Implications of Basic Neuroscience Research  |  May 13, 2013
TRIM Proteins in Therapeutic Membrane Repair of Muscular Dystrophy
Jenna Alloush; Noah Weisleder, PhD
JAMA Ophthalmology
Clinical Trials  |  May 9, 2013
Treatment With 9- cis β-Carotene–Rich Powder in Patients With Retinitis Pigmentosa:  A Randomized Crossover Trial
Ygal Rotenstreich, MD; Michael Belkin, MD; Siegal Sadetzki, MD; et al.
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems